The impact of functional imaging on radiation medicine
Open Access
- 15 September 2008
- journal article
- review article
- Published by Springer Nature in Radiation Oncology
- Vol. 3 (1) , 25
- https://doi.org/10.1186/1748-717x-3-25
Abstract
Radiation medicine has previously utilized planning methods based primarily on anatomic and volumetric imaging technologies such as CT (Computerized Tomography), ultrasound, and MRI (Magnetic Resonance Imaging). In recent years, it has become apparent that a new dimension of non-invasive imaging studies may hold great promise for expanding the utility and effectiveness of the treatment planning process. Functional imaging such as PET (Positron Emission Tomography) studies and other nuclear medicine based assays are beginning to occupy a larger place in the oncology imaging world. Unlike the previously mentioned anatomic imaging methodologies, functional imaging allows differentiation between metabolically dead and dying cells and those which are actively metabolizing. The ability of functional imaging to reproducibly select viable and active cell populations in a non-invasive manner is now undergoing validation for many types of tumor cells. Many histologic subtypes appear amenable to this approach, with impressive sensitivity and selectivity reported.Keywords
This publication has 88 references indexed in Scilit:
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaJournal of Clinical Oncology, 2007
- Prospective Study of Positron Emission Tomography for Evaluation of the Activity of Lapatinib, a Dual Inhibitor of the ErbB1 and ErbB2 Tyrosine Kinases, in Patients with Advanced TumorsJapanese Journal of Clinical Oncology, 2006
- Gastrointestinal Tract Malignancies and Positron Emission Tomography: An OverviewSeminars in Nuclear Medicine, 2006
- Therapy response evaluation in malignant pleural mesothelioma with integrated PET–CT imagingLung Cancer, 2005
- FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigationHead & Neck, 2005
- The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung CancerThe Oncologist, 2004
- Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.American Journal of Roentgenology, 1997
- Positron emission tomography in patients with glioma a predictor of prognosisCancer, 1988
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987